1. Home
  2. GCTK vs AMIX Comparison

GCTK vs AMIX Comparison

Compare GCTK & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • AMIX
  • Stock Information
  • Founded
  • GCTK 2001
  • AMIX 2014
  • Country
  • GCTK United States
  • AMIX United States
  • Employees
  • GCTK N/A
  • AMIX N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • AMIX
  • Sector
  • GCTK Health Care
  • AMIX
  • Exchange
  • GCTK Nasdaq
  • AMIX NYSE
  • Market Cap
  • GCTK 7.6M
  • AMIX 8.9M
  • IPO Year
  • GCTK N/A
  • AMIX N/A
  • Fundamental
  • Price
  • GCTK $0.26
  • AMIX $13.00
  • Analyst Decision
  • GCTK
  • AMIX
  • Analyst Count
  • GCTK 0
  • AMIX 0
  • Target Price
  • GCTK N/A
  • AMIX N/A
  • AVG Volume (30 Days)
  • GCTK 696.8K
  • AMIX 1.5M
  • Earning Date
  • GCTK 11-26-2024
  • AMIX 11-11-2024
  • Dividend Yield
  • GCTK N/A
  • AMIX N/A
  • EPS Growth
  • GCTK N/A
  • AMIX N/A
  • EPS
  • GCTK N/A
  • AMIX N/A
  • Revenue
  • GCTK N/A
  • AMIX N/A
  • Revenue This Year
  • GCTK N/A
  • AMIX N/A
  • Revenue Next Year
  • GCTK N/A
  • AMIX N/A
  • P/E Ratio
  • GCTK N/A
  • AMIX N/A
  • Revenue Growth
  • GCTK N/A
  • AMIX N/A
  • 52 Week Low
  • GCTK $0.25
  • AMIX $7.51
  • 52 Week High
  • GCTK $4.95
  • AMIX $152.00
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 21.06
  • AMIX 51.14
  • Support Level
  • GCTK $1.20
  • AMIX $9.03
  • Resistance Level
  • GCTK $1.79
  • AMIX $15.00
  • Average True Range (ATR)
  • GCTK 0.30
  • AMIX 2.19
  • MACD
  • GCTK -0.12
  • AMIX -0.00
  • Stochastic Oscillator
  • GCTK 0.85
  • AMIX 32.39

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: